Evaluation of factor VIII‐rich cryoprecipitate and the plasma fibronectin‐rich, heparin‐precipitable fraction prepared from single‐ donor plasma units
- 11 November 1987
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 27 (6) , 491-495
- https://doi.org/10.1046/j.1537-2995.1987.27688071703.x
Abstract
A plasma fibronectin-rich component was prepared by heparin-induced 4.degree.C precipitation of fresh or stored (21 days at 4.degree.C), single-donor plasma. The recovery of plasma fibronectin was 45 percent at a concentration of 0.05 mg heparin per ml (7.5 units/ml) and 75 percent at 0.1 mg per ml (15 units/ml.) The biologic activity of plasma fibronectin, as assessed by the spreading of Chinese hamster ovary cells or attachment of monocytes to gelatin-coated surfaces, was similar to that of plasma fibronectin concentrates made from fresh or stored plasma. Only 20 to 30 percent of the factor VIII activity in fresh plasma was recovered in cryoprecipitate produced after the heparin-induced precipitate containing fibronectin was removed. Cryoprecipitate prepared from the supernatant plasma that remains after heparin-induced cold precipitation in the presence of CaCl2 (5 mM) contained approximately 50 percent less factor VIII. The relatively low recovery of factor VIII in cryoprecipitate prepared from fibronectin-depleted plasma makes cryoprecipitation an unsuitable method of producing fibronectin-rich and factor VIII-rich components effectively from a single unit of fresh plasma. However, heparin-induced cold precipitation provides an efficient method for preparing plasma fibronectin concentrates from small plasma pools or single units of stored or fresh plasma.This publication has 35 references indexed in Scilit:
- Fibronectin: Applications to Clinical MedicineCRC Critical Reviews in Clinical Laboratory Sciences, 1986
- What Is the Theoretical Basis for the Therapeutic Use of Cryoprecipitates as a Source of Fibronectin?Vox Sanguinis, 1985
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985
- In Vivo Effectiveness of a High-Yield Factor VIII Concentrate Prepared in a Blood BankNew England Journal of Medicine, 1984
- Isolation of Fibronectin under Mild ConditionsVox Sanguinis, 1984
- Conformational Changes and Loss of Opsonic Function in Frozen or Heat-Treated Plasma FibronectinVox Sanguinis, 1984
- Fibronectin in liquid and frozen stored blood componentsTransfusion, 1984
- Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma.Journal of Clinical Investigation, 1983
- A Critical Assessment of Fibronectin's Opsonic Role for Bacteria and MicroaggregatesVox Sanguinis, 1983
- Preparation of Cryoprecipitated Factor VIII ConcentratesTransfusion, 1976